Cuffs and calm: can a blood pressure cuff and meditation cut heart risks?

NCT ID NCT06820970

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether using a blood pressure cuff to create brief periods of reduced blood flow (remote ischemic conditioning) combined with daily mindfulness meditation can lower the risk of heart attacks, heart failure, and chest pain in people with coronary artery disease who did not have complete artery repair. The trial will enroll 2,000 participants across multiple centers. Participants will use a device at home and listen to guided mindfulness audio sessions twice daily.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
chronic remote ischemic conditioning (device) and mindfulness therapy (behavioral)
What this could lead to
If successful, this could offer a low-cost, non-drug way to reduce heart attacks and hospitalizations in people with coronary artery disease.
What could go wrong
This is a large trial but still early-stage for this specific combination. The benefits may be modest, and adherence to daily mindfulness sessions could be challenging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fuwai Central China Cardiovascular Hospital

    RECRUITING

    Zhengzhou, Henan, 450000, China

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.